Hematología Traslacional
Harvard Medical School
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Harvard Medical School (7)
2023
-
Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress
Cells, Vol. 12, Núm. 18
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing
Bioinformatics, Vol. 38, Núm. 14, pp. 3645-3647
2021
-
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia, Vol. 35, Núm. 12, pp. 3542-3550
2020
-
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Genome Research, Vol. 30, Núm. 9, pp. 1217-1227
2019
-
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program
Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074
2017
-
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Cell Reports, Vol. 19, Núm. 1, pp. 218-224